These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22702656)

  • 21. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study.
    Gisondi P; Tessari G; Conti A; Piaserico S; Schianchi S; Peserico A; Giannetti A; Girolomoni G
    Br J Dermatol; 2007 Jul; 157(1):68-73. PubMed ID: 17553036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of severity of the cutaneous manifestations and age on the prevalence of several cardiovascular risk factors in patients with psoriasis.
    Rosa DJ; Machado RF; Matias FA; Cedrim SD; Noronha FL; Gaburri D; Gamonal A
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):348-53. PubMed ID: 21545540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities.
    Ryan C; Kirby B
    Dermatol Clin; 2015 Jan; 33(1):41-55. PubMed ID: 25412782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between psoriasis and chronic obstructive pulmonary disease: a population-based study in Taiwan.
    Chiang YY; Lin HW
    J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):59-65. PubMed ID: 21388457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical profile, morbidity, and outcome of adult-onset generalized pustular psoriasis: analysis of 102 cases seen in a tertiary hospital in Johor, Malaysia.
    Choon SE; Lai NM; Mohammad NA; Nanu NM; Tey KE; Chew SF
    Int J Dermatol; 2014 Jun; 53(6):676-84. PubMed ID: 23967807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psoriasis and cardiovascular disorders.
    Ryan C; Menter A
    G Ital Dermatol Venereol; 2012 Apr; 147(2):179-87. PubMed ID: 22481581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psoriasis and the metabolic syndrome.
    Cohen AD; Gilutz H; Henkin Y; Zahger D; Shapiro J; Bonneh DY; Vardy DA
    Acta Derm Venereol; 2007; 87(6):506-9. PubMed ID: 17989888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic comorbidities and psoriasis.
    Gisondi P; Ferrazzi A; Girolomoni G
    Acta Dermatovenerol Croat; 2010; 18(4):297-304. PubMed ID: 21251450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psoriatic patients with diabetes are prone to develop digestive organ cancers: a population-based study in Taiwan.
    Lan CC; Ko YC; Yu HS; Li WC; Wu CS; Lu YW; Yang YH; Chen GS
    J Dermatol Sci; 2012 Nov; 68(2):82-8. PubMed ID: 22986081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patients with psoriasis have insufficient knowledge of their risk of atherothrombotic disease and metabolic syndrome.
    Skiveren J; Philipsen P; Therming G
    Clin Exp Dermatol; 2015 Aug; 40(6):600-4. PubMed ID: 25847319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The risk of cancer in patients with psoriasis: a population-based cohort study in Taiwan.
    Chen YJ; Wu CY; Chen TJ; Shen JL; Chu SY; Wang CB; Chang YT
    J Am Acad Dermatol; 2011 Jul; 65(1):84-91. PubMed ID: 21458106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors.
    Miller IM; Ellervik C; Yazdanyar S; Jemec GB
    J Am Acad Dermatol; 2013 Dec; 69(6):1014-24. PubMed ID: 24238156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of risk factors for body weight increment in psoriatic patients on infliximab: a multicentre, cross-sectional study.
    Mahé E; Reguiai Z; Barthelemy H; Quiles-Tsimaratos N; Chaby G; Girard C; Estève E; Maccari F; Descamps V; Schmutz JL; Begon E; Bravard P; Maillard H; Boyé T; Beauchet A; Sigal ML;
    J Eur Acad Dermatol Venereol; 2014 Feb; 28(2):151-9. PubMed ID: 23279264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.
    Solomon DH; Avorn J; Katz JN; Weinblatt ME; Setoguchi S; Levin R; Schneeweiss S
    Arthritis Rheum; 2006 Dec; 54(12):3790-8. PubMed ID: 17136752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic immunomodulatory therapy in severe dry eye secondary to inflammation.
    Cordero-Coma M; Anzaar F; Sobrin L; Foster CS
    Ocul Immunol Inflamm; 2007; 15(2):99-104. PubMed ID: 17558834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Patients with psoriasis have an increased risk of cardiovascular diseases].
    Ahlehoff O; Gislason G; Lindhardsen J; Skov L; Hansen PR
    Ugeskr Laeger; 2012 May; 174(21):1450-2. PubMed ID: 22640784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psoriasis and the metabolic syndrome.
    Alsufyani MA; Golant AK; Lebwohl M
    Dermatol Ther; 2010; 23(2):137-43. PubMed ID: 20415820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risks of hypertension associated with cyclosporine, nonsteroidal anti-inflammatory drugs, and systemic glucocorticoids in patients with psoriasis: a nationwide population-based nested case-control study in Taiwan.
    Lee MS; Chang CH; Lin RY; Lai MS
    Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):133-40. PubMed ID: 26521982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psoriasis and Cardiovascular Disease.
    Shahwan KT; Kimball AB
    Med Clin North Am; 2015 Nov; 99(6):1227-42. PubMed ID: 26476250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comorbidities in patients with psoriasis.
    Gottlieb AB; Dann F
    Am J Med; 2009 Dec; 122(12):1150.e1-9. PubMed ID: 19958894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.